Prediction of Heart Failure in Patients with Type 2 Diabetes Mellitus- a Systematic Review and Meta-analysis
Overview
Affiliations
Background: Heart failure (HF) is a major cause of mortality and disability in type 2 diabetes mellitus (T2DM). This study sought to improve the assessment of HF risk in patients with T2DM-a step that would be critical for effective HF screening.
Methods: A systematic literature search was performed on electronic databases including MEDLINE and EMBASE, using MeSH terms 'heart failure', 'risk factor', 'T2DM', 'cardiac dysfunction', 'stage B heart failure', 'incident heart failure', 'risk assessment', 'risk impact', 'risk score', 'predictor', 'prediction' and related free text terms. The search was limited to human studies in full-length publications in English language journal from 1946 to 2014. Univariable and multivariable relative risk (RR) and hazard ratio (HR) were obtained from each study.
Results: Twenty-one studies (n=1111,569, including 507,637 subjects with T2DM) were included in this analysis with a follow-up ranging from 1 to 12 years. Associations between incident HF and risk variables described in ≥3 studies were reported. This association was greatest for insulin use (HR 2.48; 1.24-4.99), HbA1c 7.0-8.0% (2.41; 1.62-3.59), 5 years increase in age (1.47; 1.25-1.73), fasting glucose (1.28; 1.10-1.51 per standard deviation) and HbA1c (1.18; 1.14-1.23 each 1% increase). After adjustment for confounders, there were strong associations with coronary artery disease (1.77; 1.31, 2.39), HbA1c ≥ 10% (1.66; 1.45-1.89), insulin use (1.43; 1.14-1.79), HbA1c 9.0-10.0% (1.31; 1.14-1.50), fasting glucose (1.27; 1.10-1.47 per standard deviation) and 5 years increase in age (1.26; 1.13-1.40).
Conclusion: Among patients with T2DM, five common clinical variables are associated with significantly increased risk of incident HF.
Ohsugi M, Nitta D, Naito Y, Ueki K J Diabetes Investig. 2025; 16(3):414-425.
PMID: 39853963 PMC: 11871386. DOI: 10.1111/jdi.14378.
The role of multimodality imaging in diabetic cardiomyopathy: a brief review.
Adel F, Chen H Front Endocrinol (Lausanne). 2025; 15:1405031.
PMID: 39764242 PMC: 11700833. DOI: 10.3389/fendo.2024.1405031.
Wandell P, Carlsson A, Eriksson J, Wachtler C, Ruge T ESC Heart Fail. 2024; 12(1):613-621.
PMID: 39428319 PMC: 11769636. DOI: 10.1002/ehf2.15115.
Epidemiology of heart failure in diabetes: a disease in disguise.
Hoek A, Canto E, Wenker E, Bindraban N, Handoko M, Elders P Diabetologia. 2024; 67(4):574-601.
PMID: 38334818 PMC: 10904471. DOI: 10.1007/s00125-023-06068-2.
Al Badarin F, Yasine L, Hijazi R, Khalaf S, Al Mahmeed W, Manla Y J Saudi Heart Assoc. 2024; 35(2):192-199.
PMID: 38318530 PMC: 10842021. DOI: 10.37616/2212-5043.1342.